These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38243899)

  • 21. Modulation of humoral immune responses in the rat by centrally applied Met-Enk and opioid receptor antagonists: functional interactions of brain OP1, OP2 and OP3 receptors.
    Dimitrijević M; Stanojević S; Kovacević-Jovanović V; Miletić T; Vujić-Redzić V; Radulović J
    Immunopharmacology; 2000 Sep; 49(3):255-62. PubMed ID: 10996023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinorphin, an endogenous inhibitor of enkephalin-degrading enzymes, potentiates leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice.
    Honda M; Okutsu H; Matsuura T; Miyagi T; Yamamoto Y; Hazato T; Ono H
    Jpn J Pharmacol; 2001 Dec; 87(4):261-7. PubMed ID: 11829145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analgesic effects of intra-nasal enkephalins.
    Gwak HS; Cho YM; Chun IK
    J Pharm Pharmacol; 2003 Sep; 55(9):1207-12. PubMed ID: 14604463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds.
    Gray AM; Spencer PS; Sewell RD
    Br J Pharmacol; 1998 Jun; 124(4):669-74. PubMed ID: 9690858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure.
    Ciriello J; Caverson MM; McMurray JC; Bruckschwaiger EB
    Neuroscience; 2013 Oct; 250():599-613. PubMed ID: 23912034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
    Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
    J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The involvement of endogenous opioid mechanisms in the antinociceptive effects induced by antidepressant drugs, desipramine and trimipramine.
    Oztürk Y; Aydin S; Beis R; Herekman-Demir T
    Pharmacol Biochem Behav; 2006 Apr; 83(4):592-7. PubMed ID: 16712910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parallel distribution of methionine-enkephalin-Arg6-Gly7-Leu8 with methionine-enkephalin, leucine-enkephalin and methionine-enkephalin-Arg6-Phe7 in human and bovine brains.
    Ikeda Y; Nakao K; Yoshimasa T; Sakamoto M; Suda M; Yanaihara N; Imura H
    Life Sci; 1983; 33 Suppl 1():65-8. PubMed ID: 6664241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of systemic delivery of met-enkephalin and leu-enkephalin eyedrops with permeation enhancers.
    Chiou GC; Shen ZF; Zheng YQ; Li BH
    Methods Find Exp Clin Pharmacol; 1992 Jun; 14(5):361-6. PubMed ID: 1513191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine).
    Zlokovic BV; Begley DJ; Chain-Eliash DG
    Brain Res; 1985 Jun; 336(1):125-32. PubMed ID: 3891014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Design, Synthesis, and Evaluation of Novel 9-Arylxanthenedione-Based Allosteric Modulators for the δ
    Deo O; Alvi S; Pham V; Christopoulos A; Thal DM; Jörg M; Capuano B; Valant C; Scammells PJ
    J Med Chem; 2022 Sep; 65(18):12367-12385. PubMed ID: 36099150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
    Rorick-Kehn LM; Witkin JM; Statnick MA; Eberle EL; McKinzie JH; Kahl SD; Forster BM; Wong CJ; Li X; Crile RS; Shaw DB; Sahr AE; Adams BL; Quimby SJ; Diaz N; Jimenez A; Pedregal C; Mitch CH; Knopp KL; Anderson WH; Cramer JW; McKinzie DL
    Neuropharmacology; 2014 Feb; 77():131-44. PubMed ID: 24071566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition.
    Chen W; Song B; Lao L; Pérez OA; Kim W; Marvizón JC
    Neuropharmacology; 2007 Oct; 53(5):664-76. PubMed ID: 17845806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
    Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F
    J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice.
    Li N; Han ZL; Wang ZL; Xing YH; Sun YL; Li XH; Song JJ; Zhang T; Zhang R; Zhang MN; Xu B; Fang Q; Wang R
    Br J Pharmacol; 2016 Jun; 173(11):1864-80. PubMed ID: 27018797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposite role of delta 1- and delta 2-opioid receptors activated by endogenous or exogenous opioid agonists on the endogenous cholecystokinin system: further evidence for delta-opioid receptor heterogeneity.
    Noble F; Fournie-Zaluski MC; Roques BP
    Neuroscience; 1996 Dec; 75(3):917-26. PubMed ID: 8951884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.